Skip to main content

Other movement disorders

  • Chapter
Book cover Handbook of Movement Disorders
  • 944 Accesses

Abstract

Drug-induced movement disorders remain a common and under-recognized problem. Blockade of the dopaminergic system results in multiple syndromes and will be the main focus of this discussion. These syndromes are often referred to as extrapyramidal side effects (EPSE) and include tardive dyskinesia, acute dystonic reactions, akathisia, drug-induced parkinsonism and neuroleptic malignant syndrome (Figure 6.1). Serotonin syndrome and drug-induced tremor are also briefly discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Correll CU, Schenk EM. Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry 2008; 21:151–156.

    Article  PubMed  Google Scholar 

  2. Ondo WG, Hanna PA, Jankovic J. Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol. Am J Psychiatry 1999; 156:1279–1281.

    PubMed  CAS  Google Scholar 

  3. Richardson M, Bevans M, Read L, et al. Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men. Am J Psychiatry 2003; 160:1117–1124.

    Article  PubMed  Google Scholar 

  4. Lerner V, Miodownik C, Kaptsan A, et al. Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study. J Clin Psychiatry 2007; 68: 1648–54

    Article  PubMed  CAS  Google Scholar 

  5. Lorberboym M, Treves TA, Melamed E, et al. [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson’s disease. Mov Disord 2006; 21:510–514.

    Article  PubMed  Google Scholar 

  6. Carroll BT, Lee JW, Graham KT, et al. Diagnosing subtypes of neuroleptic malignant syndrome: an introduction to the Lee-Carroll Scale. Ann Clin Psychiatry 2008; 20:47–48.

    Article  PubMed  Google Scholar 

  7. Boyer E, Shannon M. The serotonin syndrome. N Eng J Med 2005; 352:112–120.

    Article  Google Scholar 

  8. Jankovic J. Tourette’s syndrome. N Engl J Med 2001; 345:1184–1192.

    Article  PubMed  CAS  Google Scholar 

  9. Nakamura K, Aminoff MJ. Huntington’s disease: clinical characteristics, pathogenesis and therapies. Drugs Today 2007; 43:97–116.

    Article  PubMed  CAS  Google Scholar 

  10. Sitburana O, Ondo WG. Tetrabenazine for hyperglycemic-induced hemichorea— hemiballismus. Mov Disord 2006; 21:2023–2025.

    Article  PubMed  Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Current Medicine Group, a part of Springer Science+Business Media

About this chapter

Cite this chapter

Ondo, W.G. (2009). Other movement disorders. In: Handbook of Movement Disorders. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-908517-04-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-908517-04-3_6

  • Publisher Name: Springer Healthcare, Tarporley

  • Print ISBN: 978-1-85873-440-8

  • Online ISBN: 978-1-908517-04-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics